April 29, 2025

First Cell-Based Gene Therapy Approved

FDA approves Zevaskyn (pz-cel), a cell-based gene therapy, for the treatment of recessive dystrophic epidermolysis bullosa.

Reuters

April 28, 2025

Delgocitinib Cream Outperforms Alitretinoin in Trial

Topical delgocitinib improved eczema severity scores and caused fewer adverse events than oral alitretinoin in adults with severe chronic hand eczema, according to a phase 3 study.

Conexiant

April 28, 2025

Patients With Hidradenitis Suppurativa at Risk for Serious Infections

A new study found that 6.4% of patients with hidradenitis suppurativa were hospitalized for serious infections not related to their skin condition, with the highest risk seen in those with chronic kidney disease, anxiety, and public insurance.

Conexiant

April 28, 2025

Granuloma Annulare: Which Light Heals Best?

Given their favorable adverse event profiles and demonstrated efficacy, both UVA-1 therapy and bath-PUVA therapy should be preferred treatment options for patients with granuloma annulare, according to a 10-year study comparing phototherapy modalities.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 18, 2025

Global Study Validates Melanoma Risk Tool

An international study of 15,731 patients found the MIA sentinel node calculator maintains accuracy across populations and now offers tighter confidence intervals after model refinement.

Conexiant

April 17, 2025

Eyebrows Signal Understanding Gaps in Conversation

Eyebrow furrows can silently signal 'I've not received enough information.'

Conexiant

April 16, 2025

Can ctDNA Monitoring Help to Predict Melanoma Recurrence?

A new report shows how droplet digital polymerase chain reaction assays focusing on monitoring the most common mutations in the genetic code in melanoma cells—BRAF V600E and BRAF V600K—may help to pre...

The ASCO Post

April 15, 2025

Preferred Lip Size Differs by Gender

"Lip plumping will mostly appeal to women rather than men (who prefer thinner lips)," finds new research showing how lip size manipulations influence perceived facial attractiveness.

Conexiant